AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31792947 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (GP-led deprescribing intervention)
Number of subjects: 145
Study 31792947 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 145
Study 31792947 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 145
Study 30225662 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-Based Practices (EBP) for children with autism spectrum disorder
Number of subjects: 46
Study 28777729 — intervention group
Group type: EXPERIMENTAL
Intervention: Constrained empirical risk minimization framework of CCA
Number of subjects: 0
Study 28777729 — intervention group
Group type: EXPERIMENTAL
Intervention: Kernel version of CCA
Number of subjects: 0
Study 28777729 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage randomized Kaczmarz method
Number of subjects: 0
Study 26407829 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexion group (affected leg elevated by 60° at the hip and knee flexed by 60°)
Number of subjects: 46
Study 26407829 — intervention group
Group type: COMPARATOR
Intervention: Extension group (affected knee fully extended postoperatively)
Number of subjects: 46
Study 23642981 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychodynamic therapy (24 subjects)
Number of subjects: 49
Study 23642981 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment alone (25 subjects)
Number of subjects: 49
Study 21871080 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot orthoses
Number of subjects: 153
Study 21871080 — intervention group
Group type: EXPERIMENTAL
Intervention: Footwear advice and footwear cost subsidy
Number of subjects: 153
Study 21871080 — intervention group
Group type: EXPERIMENTAL
Intervention: Home‐based foot and ankle exercise program
Number of subjects: 153
Study 19863217 — intervention group
Group type: EXPERIMENTAL
Intervention: No activity restrictions (NAR) combined with a moderate resistance exercise program
Number of subjects: 204
Study 19863217 — intervention group
Group type: COMPARATOR
Intervention: Activity restrictions (AR) combined with a usual care program
Number of subjects: 204
Study 16910360 — intervention group
Group type: EXPERIMENTAL
Intervention: Lichtenstein mesh
Number of subjects: 70
Study 16910360 — intervention group
Group type: COMPARATOR
Intervention: Rutkow-Robbins plug and mesh
Number of subjects: 70
Study 15575902 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 214
Study 15575902 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 214
Study 11759858 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix allograft
Number of subjects: 9
Study 11759858 — intervention group
Group type: COMPARATOR
Intervention: Connective tissue graft with coronally positioned flap
Number of subjects: 9
Study 9387963 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation assessment using rapid airway occlusion technique
Number of subjects: 12
Study 9387963 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography scans
Number of subjects: 12
Study 9387963 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of interrupter resistance (Rint)
Number of subjects: 12
Study 9387963 — intervention group
Group type: EXPERIMENTAL
Intervention: Static inflation volume-pressure (V-P) curve assessment
Number of subjects: 12
Study 7663467 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality 1 bone
Number of subjects: 2131
Study 7663467 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality 2 bone
Number of subjects: 2131
Study 7663467 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality 3 bone
Number of subjects: 2131
Study 3111179 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel aldose reductase inhibitor (ARI)
Number of subjects: 30
Study 3111179 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients without AN)
Number of subjects: 30
Study 3111179 — intervention group
Group type: EXPERIMENTAL
Intervention: ARI treatment
Number of subjects: 30
Study 31531997 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrition supplements (3 supplements/day for 5 days)
Number of subjects: 108
Study 31531997 — intervention group
Group type: COMPARATOR
Intervention: Standard polymeric supplements (3 supplements/day for 5 days)
Number of subjects: 108
Study 31531997 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrition and Standard polymeric supplements
Number of subjects: 108
Study 30848558 — intervention group
Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP) plus nonbiologic background medication (NBBM)
Number of subjects: 317
Study 30848558 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus nonbiologic background medication (NBBM)
Number of subjects: 317
Study 26803169 — intervention group
Group type: EXPERIMENTAL
Intervention: SeY-100/d (100 μg Se/day)
Number of subjects: 117
Study 26803169 — intervention group
Group type: EXPERIMENTAL
Intervention: SeY-50/d (50 μg Se/day)
Number of subjects: 117
Study 26803169 — intervention group
Group type: EXPERIMENTAL
Intervention: SeY-200/d (200 μg Se/day)
Number of subjects: 117
Study 26803169 — intervention group
Group type: EXPERIMENTAL
Intervention: SeO-50/d (50 μg Se/day)
Number of subjects: 117
Study 26803169 — intervention group
Group type: COMPARATOR
Intervention: Onion (control)
Number of subjects: 117
Study 26803169 — intervention group
Group type: EXPERIMENTAL
Intervention: Se supplementation (various doses)
Number of subjects: 117
Study 25518754 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP) and Samidorphan (SAM) in a 1:1 ratio for 7 days
Number of subjects: 0
Study 25518754 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23223915 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 50
Study 23223915 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 50
Study 21519309 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion (1 mg/kg per hour) with patient-controlled analgesia morphine for the first 48 hours after surgery
Number of subjects: 60
Study 21519309 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural analgesia with patient-controlled analgesia morphine for the first 48 hours after surgery
Number of subjects: 60
Study 21519309 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (TEA and IL)
Number of subjects: 60
Study 18211939 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine
Number of subjects: 65
Study 18211939 — intervention group
Group type: COMPARATOR
Intervention: 0.5% levobupivacaine/2% lidocaine mixture
Number of subjects: 65
Study 17062741 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mM CuSO4
Number of subjects: 14
Study 17062741 — intervention group
Group type: EXPERIMENTAL
Intervention: Amine fluoride (250 ppm F)
Number of subjects: 14
Study 17062741 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper and amine fluoride combined
Number of subjects: 14
Study 17062741 — intervention group
Group type: COMPARATOR
Intervention: Placebo (water)
Number of subjects: 14
Study 15536784 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline microspheres
Number of subjects: 30
Study 15536784 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine gel
Number of subjects: 30
Study 10903240 — intervention group
Group type: EXPERIMENTAL
Intervention: montelukast at 5 mg/d for 2 days
Number of subjects: 13
Study 10903240 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 13
Study 10903240 — intervention group
Group type: EXPERIMENTAL
Intervention: montelukast
Number of subjects: 13
Study 9305235 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed weed extract (1:2500 wt/vol to 1:10 wt/vol) administered daily for 12 to 16 weeks with 5.2 mg intranasal cromolyn pretreatment.
Number of subjects: 27
Study 9305235 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group).
Number of subjects: 27
Study 8454221 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nifedipine
Number of subjects: 0
Study 8454221 — intervention group
Group type: COMPARATOR
Intervention: Parenteral hydralazine
Number of subjects: 0
Study 3096592 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine suspension, 30 mg b.i.d.
Number of subjects: 25
Study 3096592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 29800001 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP users (72 participants, mean use 6.4 hours per night)
Number of subjects: 182
Study 29800001 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP users (72 participants)
Number of subjects: 182
Study 29800001 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP users (women subgroup)
Number of subjects: 182
Study 29800001 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP users (men subgroup)
Number of subjects: 182
Study 29800001 — intervention group
Group type: COMPARATOR
Intervention: Nonusers (110 participants, mean use 0 hours per night)
Number of subjects: 182
Study 26848545 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% 1 repetition maximum (1RM) resistance training
Number of subjects: 15
Study 26848545 — intervention group
Group type: COMPARATOR
Intervention: 30% 1 repetition maximum (1RM) resistance training
Number of subjects: 15
Study 25054430 — intervention group
Group type: EXPERIMENTAL
Intervention: Dofetilide (pure hERG potassium channel blocker)
Number of subjects: 22
Study 25054430 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinidine (blocks hERG and calcium currents)
Number of subjects: 22
Study 25054430 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine (blocks hERG and late sodium currents)
Number of subjects: 22
Study 25054430 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (blocks hERG and calcium currents)
Number of subjects: 22
Study 22209475 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromechanical device systems (2 types), 5 days per week for 8 weeks
Number of subjects: 130
Study 22209475 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromechanical systems
Number of subjects: 130
Study 20129332 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic uterine artery occlusion and myomectomy (LUAO-M)
Number of subjects: 90
Study 20129332 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic surgery supracervical hysterectomy (LSH)
Number of subjects: 90
Study 20129332 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic myomectomy (LM)
Number of subjects: 90
Study 17660482 — intervention group
Group type: EXPERIMENTAL
Intervention: vildagliptin 100 mg qd
Number of subjects: 18
Study 17660482 — intervention group
Group type: EXPERIMENTAL
Intervention: digoxin (0.5 mg, then 0.25 mg qd on days 2‐7)
Number of subjects: 18
Study 17660482 — intervention group
Group type: EXPERIMENTAL
Intervention: combination vildagliptin/digoxin for 7 days
Number of subjects: 18
Study 16207773 — intervention group
Group type: EXPERIMENTAL
Intervention: Social monitoring (attention to social information and cues)
Number of subjects: 0
Study 16207773 — intervention group
Group type: EXPERIMENTAL
Intervention: Decoding of social cues in faces and voices
Number of subjects: 0
Study 12381481 — intervention group
Group type: EXPERIMENTAL
Intervention: IUD use
Number of subjects: 383
Study 12381481 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 383
Study 10999557 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 1,000 mg twice daily
Number of subjects: 324
Study 10999557 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 2,000 mg twice daily
Number of subjects: 324
Study 10999557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324
Study 10999557 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 1,000 mg and 2,000 mg
Number of subjects: 324
Study 8963746 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive training (20 min per day, 5 phases of increasing difficulty over three soccer seasons)
Number of subjects: 600
Study 8963746 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal training, no special balance training)
Number of subjects: 600
Study 1599635 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate supplementation (1 g for 12 weeks)
Number of subjects: 103
Study 1599635 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate supplementation continued for 36 weeks after initial 12 weeks if blood pressure decreased by at least 5 mm Hg
Number of subjects: 103
Study 1599635 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4 weeks followed by 12 weeks run-out)
Number of subjects: 103
Study 3830333 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 electroconvulsive therapy
Number of subjects: 0
Study 3830333 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 electroconvulsive therapy
Number of subjects: 0
Study 3830333 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 3 electroconvulsive therapy
Number of subjects: 0
Study 31390289 — intervention group
Group type: EXPERIMENTAL
Intervention: language‐focused intervention
Number of subjects: 938
Study 31390289 — intervention group
Group type: COMPARATOR
Intervention: business‐as‐usual control
Number of subjects: 938
Study 29980177 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored, theory informed knowledge translation (KT) interventions
Number of subjects: 24
Study 29980177 — intervention group
Group type: COMPARATOR
Intervention: Usual dissemination practices
Number of subjects: 24
Study 26763605 — intervention group
Group type: EXPERIMENTAL
Intervention: OFDI-guided PCI
Number of subjects: 0
Study 26763605 — intervention group
Group type: COMPARATOR
Intervention: IVUS-guided PCI
Number of subjects: 0
Study 24239386 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy
Number of subjects: 151
Study 24239386 — intervention group
Group type: COMPARATOR
Intervention: Standard radiation therapy
Number of subjects: 151
Study 22527168 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy product intake (1 SD increase)
Number of subjects: 1798
Study 22527168 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy protein intake (1 SD increase)
Number of subjects: 1798
Study 22527168 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake (25% increase)
Number of subjects: 1798
Study 22527168 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium intake (25% increase)
Number of subjects: 1798
Study 22527168 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal protein intake (1 SD increase)
Number of subjects: 1798
Study 22527168 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy protein and calcium intake
Number of subjects: 1798
Study 22527168 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary associations with IGFBP-3 or IGF-II
Number of subjects: 1798
Study 20154071 — intervention group
Group type: EXPERIMENTAL
Intervention: Helmet CPAP
Number of subjects: 47
Study 20154071 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen therapy (control)
Number of subjects: 47
Study 18621791 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost once daily
Number of subjects: 152
Study 18621791 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost twice daily/once daily
Number of subjects: 152
Study 18621791 — intervention group
Group type: COMPARATOR
Intervention: Timolol twice daily
Number of subjects: 152
Study 18621791 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 152
Study 18621791 — intervention group
Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 152
Study 15752661 — intervention group
Group type: EXPERIMENTAL
Intervention: Bishop score
Number of subjects: 266
Study 15752661 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic cervical length
Number of subjects: 266
Study 12050495 — intervention group
Group type: EXPERIMENTAL
Intervention: Mistletoe lectin
Number of subjects: 45
Study 12050495 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 45
Study 10471604 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosol ribavirin
Number of subjects: 41
Study 10471604 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9% (placebo)
Number of subjects: 41
Study 8946267 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins (C, E, beta-carotene)
Number of subjects: 0
Study 8946267 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31268266 — intervention group
Group type: EXPERIMENTAL
Intervention: 25G Sprotte needle
Number of subjects: 655
Study 31268266 — intervention group
Group type: EXPERIMENTAL
Intervention: 27G Sprotte needle
Number of subjects: 655
Study 31268266 — intervention group
Group type: EXPERIMENTAL
Intervention: 26G Atraucan needle
Number of subjects: 655
Study 31268266 — intervention group
Group type: EXPERIMENTAL
Intervention: 25G Quincke needle (midline approach)
Number of subjects: 655
Study 31268266 — intervention group
Group type: EXPERIMENTAL
Intervention: 25G Quincke needle (paramedian approach)
Number of subjects: 655
Study 31268266 — intervention group
Group type: EXPERIMENTAL
Intervention: Midline approach
Number of subjects: 655
Study 31268266 — intervention group
Group type: COMPARATOR
Intervention: Paramedian approach
Number of subjects: 655
Study 28733256 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 48
Study 28733256 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 48
Study 28733256 — intervention group
Group type: COMPARATOR
Intervention: Control experiment (order-irrelevant font color classification)
Number of subjects: 48
Study 25301853 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled second-look endoscopy (SLE)
Number of subjects: 262
Study 25301853 — intervention group
Group type: COMPARATOR
Intervention: Non-SLE (control group)
Number of subjects: 262
Study 24095905 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest decile of dietary folate intake
Number of subjects: 1153
Study 21059740 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (PUFAs) 3 g/day until ECV and 2 g/day thereafter
Number of subjects: 204
Study 21059740 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 18664159 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryosurgery followed by diclofenac sodium 3% gel for 90 days
Number of subjects: 714
Study 18664159 — intervention group
Group type: COMPARATOR
Intervention: Cryosurgery alone
Number of subjects: 714
Study 15677892 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean dietary pattern (high consumption of olive oil, vegetables, fruit, fish, and lean meat)
Number of subjects: 442
Study 15677892 — intervention group
Group type: EXPERIMENTAL
Intervention: Western dietary pattern
Number of subjects: 442
Study 15677892 — intervention group
Group type: EXPERIMENTAL
Intervention: Snacks dietary pattern
Number of subjects: 442
Study 15677892 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweets and snacks dietary pattern
Number of subjects: 442
Study 15677892 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat and proteins dietary pattern
Number of subjects: 442
Study 12870375 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-hydrolysate formula (n = 8)
Number of subjects: 16
Study 12870375 — intervention group
Group type: COMPARATOR
Intervention: Soy formula (control group, n = 8)
Number of subjects: 16
Study 10848660 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 232
Study 10848660 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 232
Study 10848660 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 232
Study 10848660 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 232
Study 8803370 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (2 or 4 mg)
Number of subjects: 269
Study 8803370 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 269
Study 1735350 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 13
Study 1735350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 6697270 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte transfusions
Number of subjects: 43
Study 6697270 — intervention group
Group type: COMPARATOR
Intervention: No granulocyte transfusions (Control)
Number of subjects: 43
Study 6697270 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B
Number of subjects: 43
Study 6697270 — intervention group
Group type: EXPERIMENTAL
Intervention: Fungal infections
Number of subjects: 43
Study 30218263 — intervention group
Group type: EXPERIMENTAL
Intervention: da Vinci Single-Site™ cholecystectomy (dVSSC)
Number of subjects: 60
Study 30218263 — intervention group
Group type: COMPARATOR
Intervention: Single-Port Laparoscopic Cholecystectomy (SILC)
Number of subjects: 60
Study 29861216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical mobilization
Number of subjects: 30
Study 29861216 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 29861216 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 30
Study 26607696 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual chest compressions on concrete floor
Number of subjects: 24
Study 26607696 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual chest compressions on firm standard mattress
Number of subjects: 24
Study 26607696 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual chest compressions on pressure-relieving mattress
Number of subjects: 24
Study 26607696 — intervention group
Group type: COMPARATOR
Intervention: Mechanical chest compressions on concrete floor
Number of subjects: 24
Study 26607696 — intervention group
Group type: COMPARATOR
Intervention: Mechanical chest compressions on firm standard mattress
Number of subjects: 24
Study 26607696 — intervention group
Group type: COMPARATOR
Intervention: Mechanical chest compressions on pressure-relieving mattress
Number of subjects: 24
Study 26607696 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual CPR
Number of subjects: 24
Study 23943282 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.4 % glyceryl trinitrate (GTN) ointment every 12 hours for four postoperative weeks
Number of subjects: 104
Study 23943282 — intervention group
Group type: COMPARATOR
Intervention: Control group (no GTN ointment)
Number of subjects: 104